Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03222375 · ClinicalTrials.gov registry record
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
A clinical trial of Autism Spectrum Disorder and Autistic Disorder, sponsored by American Federation of Medical Synergetics.
- Recruiting
- Registry status
- 80
- Enrollment target
- 2
- Study locations
NCT03222375 is a study of Autism Spectrum Disorder and Autistic Disorder that is actively recruiting participants, run by American Federation of Medical Synergetics. The registered enrollment target is 80 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (41% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03222375, a study of Autism Spectrum Disorder and Autistic Disorder, is actively recruiting participants, sponsored by American Federation of Medical Synergetics.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
Locomotor, transport and information functions in human body systems are carried out by active media in autowave regimes! Any living organism is a (micro-macro-mega) hierarchy of autowave subsystems-an ensemble of loosely coupled subsystems of a simpler structure. From the highest levels of the hierarchy, Autowave Codes-Signals arrive, which determine the transitions of subsystems from one autowave regime to another Autowave interaction (of Complex Coherent Action). Autowave interaction is a process associated with the evolution and interaction of spatial and wave structures in the active media of the organism. Chaos in organism functioning tells about health. Periodicity - Autowave reverberator may presage a disease - Autism Spectrum Disorder; Chaotic nature of oscillations in active media of physiological systems is more optimal for their vital functions than periodic one. Firstly, systems that function in chaotic regimes, can re-arrange themselves faster and easier in case of change of environmental conditions, i.e. the so called adaptive control is more easily implemented in them. Secondly, "spreading" of oscillations strength along comparatively wide frequency band takes place in chaotic regime. When an organism is young and healthy, physiological systems show the elements of chaotic behavior, i.e. irregularity and chaotic dynamics are the extremely important characteristics of health. Decrease in changeability and appearance of stable periodicity of Autowave reverberator are often connected with Autism. The main purpose is to study brain plasticity (the changes that occur in the brain through Autowave reverberator) in children with autism. Research suggests that during development, the brains of children may change in response to their Autowave reverberator differently than the brains of typically developing individuals. Investigators want to understand why and how this difference may contribute to the symptoms of autism spectrum disorder (ASD). In this stu
Conditions Studied
Interventions
- DEVICE SQUED™ series 28.1 home-use
Study Locations (2)
Kentucky
- World Autism Center, American Federation of Medical Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology WOMS - Louisville
Solonka Village, Urozayna Street 41
- Clinic of Synergetics, Department of Neurology; Cognitive Neurology/Neuropsychology of the World Organization of Medical Synergetics - Lviv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-09-26 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03222375
The ClinicalTrials.gov registry entry for NCT03222375 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (41% lower). The listed sponsor is American Federation of Medical Synergetics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which SQUED™ series 28.1 home-use is the first listed.
NCT03222375 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, Solonka Village, Urozayna Street 41.
Frequently Asked Questions
What is clinical trial NCT03222375 about?
NCT03222375 is a clinical study titled "SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism". Locomotor, transport and information functions in human body systems are carried out by active media in autowave regimes! Any living organism is a (micro-macro-mega) hierarchy of autowave subsystems-an ensemble of loosely coupled subsystems of a simpler structure. From the highest levels of the hier...
What is the current status of trial NCT03222375?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2017-09-26. Estimated completion is 2027-12.
What conditions does trial NCT03222375 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Autistic Disorder, Neurodevelopmental Disorders, Mental Disorders, Nervous System Diseases.
What interventions are being tested in trial NCT03222375?
The interventions under investigation include: SQUED™ series 28.1 home-use (DEVICE).
Who is sponsoring clinical trial NCT03222375?
This trial is sponsored by American Federation of Medical Synergetics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03222375 being conducted?
This trial has 2 study locations across Kentucky, Solonka Village, Urozayna Street 41. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.